179 related articles for article (PubMed ID: 30114926)
1. Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps.
Hatzidakis A; Perisinakis K; Kalarakis G; Papadakis A; Savva E; Ippolito D; Karantanas A
Acta Radiol; 2019 May; 60(5):561-568. PubMed ID: 30114926
[TBL] [Abstract][Full Text] [Related]
2. CT liver perfusion in patients with hepatocellular carcinoma: can we modify acquisition protocol to reduce patient exposure?
Kalarakis G; Perisinakis K; Akoumianakis E; Karageorgiou I; Hatzidakis A
Eur Radiol; 2021 Mar; 31(3):1410-1419. PubMed ID: 32876834
[TBL] [Abstract][Full Text] [Related]
3. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
Ippolito D; Sironi S; Pozzi M; Antolini L; Invernizzi F; Ratti L; Leone EB; Fazio F
Eur J Radiol; 2010 Jan; 73(1):148-52. PubMed ID: 19054640
[TBL] [Abstract][Full Text] [Related]
4. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
Fischer MA; Kartalis N; Grigoriadis A; Loizou L; Stål P; Leidner B; Aspelin P; Brismar TB
Eur Radiol; 2015 Nov; 25(11):3123-32. PubMed ID: 25903707
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
[TBL] [Abstract][Full Text] [Related]
6. Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease.
Li JP; Zhao DL; Jiang HJ; Huang YH; Li DQ; Wan Y; Liu XD; Wang JE
Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):43-9. PubMed ID: 21269934
[TBL] [Abstract][Full Text] [Related]
7. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
[TBL] [Abstract][Full Text] [Related]
8. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
Fischer MA; Marquez HP; Gordic S; Leidner B; Klotz E; Aspelin P; Alkadhi H; Brismar TB
Eur Radiol; 2017 Mar; 27(3):1074-1080. PubMed ID: 27368924
[TBL] [Abstract][Full Text] [Related]
9. Tumor attenuation and quantitative analysis of perfusion parameters derived from tri-phasic CT scans in hepatocellular carcinoma: Relationship with histological grade.
Pang G; Shao C; Lv Y; Zhao F
Medicine (Baltimore); 2021 Apr; 100(16):e25627. PubMed ID: 33879737
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
[TBL] [Abstract][Full Text] [Related]
11. [MSCT perfusion imaging and its correlation with perfusion parameters, survivin expression, MVD, and pathologic grade in hepatocellular carcinomas].
Long X; Cao J; Shi L; Li W; Liu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1096-102. PubMed ID: 19952399
[TBL] [Abstract][Full Text] [Related]
12. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
Sahani DV; Holalkere NS; Mueller PR; Zhu AX
Radiology; 2007 Jun; 243(3):736-43. PubMed ID: 17517931
[TBL] [Abstract][Full Text] [Related]
13. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations.
Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Meloni F; Invernizzi F; Valsecchi MG; Fazio F
J Comput Assist Tomogr; 2008; 32(6):855-8. PubMed ID: 19204443
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
[No Abstract] [Full Text] [Related]
16. Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.
Lu Q; Zhang XL; Han H; Huang BJ; Ding H; Wang WP
J Ultrasound Med; 2019 Oct; 38(10):2601-2608. PubMed ID: 30697787
[TBL] [Abstract][Full Text] [Related]
17. Intraobserver and Interobserver Agreement in the Evaluation of Tumor Vascularization With Computed Tomography Perfusion in Cirrhotic Patients With Hepatocellular Carcinoma.
Ippolito D; Casiraghi AS; Talei Franzesi C; Bonaffini PA; Fior D; Sironi S
J Comput Assist Tomogr; 2016; 40(1):152-9. PubMed ID: 26484957
[TBL] [Abstract][Full Text] [Related]
18. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
19. VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy Dynamic Contrast Enhanced CT.
Thaiss WM; Kaufmann S; Kloth C; Nikolaou K; Bösmüller H; Horger M
Eur J Radiol; 2016 Nov; 85(11):2036-2041. PubMed ID: 27776657
[TBL] [Abstract][Full Text] [Related]
20. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.
Kaltenbach B; Wichmann JL; Pfeifer S; Albrecht MH; Booz C; Lenga L; Hammerstingl R; D'Angelo T; Vogl TJ; Martin SS
Eur J Radiol; 2018 Aug; 105():20-24. PubMed ID: 30017280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
